Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer cell detection device for the diagnosis of bladder cancer from urine.
MacGregor M, Safizadeh Shirazi H, Chan KM, Ostrikov K, McNicholas K, Jay A, Chong M, Staudacher AH, Michl TD, Zhalgasbaikyzy A, Brown MP, Kashani MN, Di Fiore A, Grochowski A, Robb S, Belcher S, Li J, Gleadle JM, Vasilev K. MacGregor M, et al. Among authors: kashani mn. Biosens Bioelectron. 2021 Jan 1;171:112699. doi: 10.1016/j.bios.2020.112699. Epub 2020 Oct 7. Biosens Bioelectron. 2021. PMID: 33068879
Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single-blinded, split-face randomized trial.
Dastgheib M, Heidari S, Azizipour A, Kavyani M, Lajevardi V, Ehsani AH, Teimourpour A, Daneshpazhooh M, Kashani MN, Balighi K. Dastgheib M, et al. Among authors: kashani mn. J Cosmet Dermatol. 2024 Jun;23(6):1992-2000. doi: 10.1111/jocd.16258. Epub 2024 Mar 1. J Cosmet Dermatol. 2024. PMID: 38429946 Clinical Trial.
Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate-to-severe glabellar lines: A non-inferiority double blinded randomized controlled trial.
Afshani SM, Samadi A, Ayatollahi A, Kashani MN, Ahmad Nasdrollahi S, Hosseini H, Rezagholi Z, Hedayatjoo B, Hazegh Fetratjoo D, Ghobadi MA, Anari A, Saeedifar S, Firooz A. Afshani SM, et al. Among authors: kashani mn. J Cosmet Dermatol. 2022 Jun;21(6):2398-2406. doi: 10.1111/jocd.14939. Epub 2022 Apr 9. J Cosmet Dermatol. 2022. PMID: 35340107 Clinical Trial.
14 results